OPRL1 (opioid receptor-like 1) is a G-protein-coupled receptor activated by the neuropeptide nociceptin/orphanin FQ. It modulates pain perception, cognition, inflammation, and immune responses . The HRP-conjugated OPRL1 antibody is a detection tool designed for enzyme-linked immunosorbent assays (ELISA) and related applications. Horseradish peroxidase (HRP) allows direct signal amplification, eliminating the need for secondary antibodies and streamlining workflows .
HRP-conjugated antibodies bind to OPRL1 antigens in assays, with HRP catalyzing chromogenic reactions (e.g., TMB substrate) to generate detectable signals. This conjugation enhances sensitivity and reduces assay time compared to traditional two-step detection methods .
The HRP-conjugated OPRL1 antibody is primarily validated for ELISA, though its utility extends to broader immunoassays. Below are key applications:
Dilution Optimization: Recommended dilutions vary (e.g., 1:1000–5000 for ELISA ), requiring titration for optimal signal-to-noise ratios.
Cross-Reactivity: HRP-conjugated OPRL1 antibodies are typically human-specific, though some sources suggest potential reactivity with mouse/rat samples (e.g., Source ) .
Stability: Long-term storage at -20°C ensures functionality, but repeated freeze-thaw cycles may compromise activity .